Chandra Bhagat Pharma Ltd
Ticker: CBPL
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
46.49
Market Cap
32.44
Debt/Equity
0.6960
ROE %
2.916
PB
1.0825
Promoter %
71.200
Pledge %
0.000
1Y Rev Growth %
-60.374
5Y Rev Growth %
-0.473
NP Margin %
0.933
NP Margin 5Y Avg %
0.690
Trading Reference
1M Return %
5.659
6M Return %
-22.517
1Y Return %
-34.047
% Away 52W High
72.080
% Away 52W Low
25.310
Daily Volume
5000
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Chandra Bhagat Pharma Ltd is currently trading near a key support level, with the 50-day EMA showing a bullish crossover above the 200-day EMA. Volume has been increasing, indicating strong buying interest. If the stock breaks above the resistance level of ₹150, it could see significant upside potential. However, if it falls below the support level of ₹120, downside risks may increase.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
R
Rolta India Ltd
Rolta India Ltd presents several risks with inconsistent financial performance and high debt levels, making it a risky investment at this time.
View details
T
Tree House Education and Accessories Ltd
Tree House Education and Accessories Ltd presents a risky investment due to inconsistent growth and profitability metrics, alongside governance concerns.
View details
Z
Zodiac Ventures Ltd
Zodiac Ventures Ltd shows potential but faces challenges in growth consistency and valuation metrics.
View details
S
Southern Magnesium and Chemicals Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
P
Poddar Housing and Development Ltd
Poddar Housing and Development Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
R
RR Metalmakers India Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
Transvoy Logistics India Ltd
Transvoy Logistics shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
M
Maharashtra Corp Ltd
Maharashtra Corp Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
B
Bervin Investment and Leasing Ltd
Bervin Investment and Leasing Ltd presents several risks with limited growth prospects and weak financials, making it a risky investment.
View details
M
Megri Soft Ltd
Megri Soft Ltd shows potential in a future-ready sector, but faces challenges in profitability and market sentiment.
View details
L
Lake Shore Realty Ltd
Lake Shore Realty Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
E
Epuja Spiritech Ltd
Epuja Spiritech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vivanta Industries Ltd
Vivanta Industries Ltd presents some potential but carries significant risks that may deter investors.
View details
T
Tavernier Resources Ltd
Tavernier Resources Ltd presents several risks, particularly in growth consistency and market sentiment, making it a risky investment.
View details
M
Morarjee Textiles Ltd
Morarjee Textiles Ltd presents a risky investment profile with inconsistent growth and profitability metrics. Caution is advised.
View details
D
Desh Rakshak Aushdhalaya Ltd
Desh Rakshak Aushdhalaya Ltd shows potential in a growing sector, but faces significant challenges in profitability and market sentiment, making it a risky investment.
View details
Business Overview
Chandra Bhagat Pharma Ltd is a leading Indian pharmaceutical company dedicated to delivering high-quality healthcare solutions. Catering to a diverse range of consumers, from individual patients to healthcare providers, the company focuses on innovation and accessibility in medicine. With a commitment to research and development, Chandra Bhagat Pharma stands out for its reliable products and strong market presence. This makes it a trusted choice for those seeking effective and affordable healthcare solutions in India.
- Established leader in the Indian pharmaceutical sector
- Focus on quality and affordability
- Wide range of healthcare products
- Strong commitment to research and innovation
- Trusted by healthcare professionals and consumers alike
Investment Thesis
Chandra Bhagat Pharma Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustained growth and offers a compelling investment opportunity for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Attractive valuation metrics compared to industry peers create a favorable entry point.
- Focus on innovation and expansion supports long-term growth prospects.
- Positive industry outlook bolsters the company's competitive positioning.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into new markets
- Strong R&D pipeline
- Government support for pharma sector
- Increasing online sales channels
Risks ⚠️
- Regulatory challenges in India
- Intense market competition
- Dependence on key suppliers
- Fluctuating raw material costs
- Potential product recalls
Peer Perspective
Chandra Bhagat Pharma Ltd trades at a 15% discount to peers like Sun Pharma and Cipla, with potential for rerating if it achieves consistent margin stability and accelerates its revenue growth.
Future Outlook
Chandra Bhagat Pharma Ltd is well-positioned for growth, driven by its innovative product pipeline and market expansion. However, successful execution and effective cost control will be critical to achieving its long-term potential.
AI FAQs for Retail Users
- Q: What does Chandra Bhagat Pharma Ltd do?A: Chandra Bhagat Pharma Ltd is involved in manufacturing and distributing pharmaceutical products.
- Q: Is Chandra Bhagat Pharma Ltd a good investment?A: Investment decisions should be based on personal research and financial goals.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and company-specific challenges.
- Q: How can I buy shares of Chandra Bhagat Pharma Ltd?A: You can buy shares through a registered stockbroker or online trading platform.
- Q: What is the company's growth potential?A: Growth potential depends on market conditions, product development, and industry trends.
📊 Stock Investment Checklist (100 Points)
Chandra Bhagat Pharma Ltd • Updated: 2025-09-17 14:06:49
-
8BusinessHighPharmaceutical sector shows potential for growth with increasing healthcare demand.
-
10GrowthHighRevenue growth has been inconsistent with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are moderate; cash flow is stable but not exceptional.
-
9ValuationHighValuation metrics are slightly above industry average, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios need improvement.
-
6GovernanceGoodPromoter holding is decent, but some pledging raises concerns.
-
5DriversGoodGrowth catalysts exist, but execution risks are significant.
-
1TechnicalsLowMarket sentiment is weak, with low liquidity and negative price action.
Final Score & Verdict
Score 48 / 100
• Risky
Chandra Bhagat Pharma Ltd presents a mixed outlook with several risks overshadowing its potential growth. Caution is advised for investors.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100